These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2543598)

  • 81. Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis.
    Sennesael J; Verbeelen D
    Eur J Clin Pharmacol; 1986; 30(3):257-62. PubMed ID: 3015637
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex.
    Ogihara T; Mikami H; Katahira K; Otsuka A
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):46S-51S. PubMed ID: 2009148
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors.
    Kaplan RP; Potter TS; Fox JN
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 2):364-6. PubMed ID: 1569260
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Worldwide experience with enalapril].
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Presse Med; 1985 Dec; 14(44):2245-55. PubMed ID: 3003730
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.
    Kreft-Jais C; Plouin PF; Tchobroutsky C; Boutroy MJ
    Br J Obstet Gynaecol; 1988 Apr; 95(4):420-2. PubMed ID: 2838069
    [No Abstract]   [Full Text] [Related]  

  • 86. Angiotensin converting enzyme inhibitor cough: lessons from heart-lung transplantation.
    Gabbay E; Small T; Corris PA
    Respirology; 1998 Mar; 3(1):39-40. PubMed ID: 9657658
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.
    Hagley MT; Benak RL; Hulisz DT
    Ann Pharmacother; 1992 Jun; 26(6):780-1. PubMed ID: 1611160
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.
    Rucinska EJ; Small R; Mulcahy WS; Snyder DL; Rodel PV; Rush JE; Smith RD; Walker JF; Irvin JD
    Med Toxicol Adverse Drug Exp; 1989; 4(2):144-52. PubMed ID: 2541310
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases].
    Plouin PF; Tchobroutsky C
    Presse Med; 1985 Dec; 14(43):2175-8. PubMed ID: 3001690
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
    Lunde H; Hedner T; Samuelsson O; Lötvall J; Andrén L; Lindholm L; Wiholm BE
    BMJ; 1994 Jan; 308(6920):18-21. PubMed ID: 8298346
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.
    Odum J; Carson P; Russell G
    Postgrad Med J; 1991 Apr; 67(786):354-7. PubMed ID: 2068028
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Side effects and metabolic effects of converting enzyme inhibitors.
    Omae T; Kawano Y; Yoshida K
    Clin Exp Hypertens A; 1987; 9(2-3):635-42. PubMed ID: 3038427
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Captopril and enalapril improve cognition and depressed mood in hypertensive patients.
    Braszko JJ; Karwowska-Polecka W; Halicka D; Gard PR
    J Basic Clin Physiol Pharmacol; 2003; 14(4):323-43. PubMed ID: 15198305
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Zinc metabolism in patients treated with captopril versus enalapril.
    Golik A; Modai D; Averbukh Z; Sheffy M; Shamis A; Cohen N; Shaked U; Dolev E
    Metabolism; 1990 Jul; 39(7):665-7. PubMed ID: 2195291
    [TBL] [Abstract][Full Text] [Related]  

  • 95. General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers.
    Dahlöf C; Dimenäs E
    Eur J Clin Pharmacol; 1992; 43(4):375-9. PubMed ID: 1451716
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.
    Arauz-Pacheco C; Ramirez LC; Rios JM; Raskin P
    Am J Med; 1990 Dec; 89(6):811-3. PubMed ID: 2123605
    [No Abstract]   [Full Text] [Related]  

  • 97. Post-marketing studies of subjective side effects; a case for strict methodological criteria and careful analysis of data.
    Strocchi E; Valtancoli G; Ricci C; Malini PL; Bassein L; Ambrosioni E
    Pharmacol Res; 1992; 25 Suppl 1():79-80. PubMed ID: 1508819
    [No Abstract]   [Full Text] [Related]  

  • 98. Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study.
    Visser LE; Stricker BH; van der Velden J; Paes AH; Bakker A
    J Clin Epidemiol; 1995 Jun; 48(6):851-7. PubMed ID: 7769416
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
    Ferner RE; Simpson JM; Rawlins MD
    Br Med J (Clin Res Ed); 1987 May; 294(6580):1119-20. PubMed ID: 3034372
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prospective trial on captopril-related cough.
    Lefebvre J; Poirier L; Lacourcière Y
    Ann Pharmacother; 1992 Feb; 26(2):161-4. PubMed ID: 1554923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.